ULU, a UK-based CBD business, has entered a ground-breaking partnership with the Harley Street Hospital. Basically, it means ULU will engage in a medical research program with The Harley Street Hospital.
The motive of this partnership is to explore new ways to use CBD for managing pain and treating problematic issues in people’s lives. Both the entities are ready to work for improving people’s lives for the better.
It allows people to shop a wide range of effective CBD products for dealing with many health issues they encounter in their everyday routine. After this unique partnership, ULU has become the only CBD brand globally to be a part of a medical research program at a world-famous hospital, 19 Harley Street Hospital.
Over the course of time, millions of people have come to know about the benefits of using CBD in treating many common health issues. A lot of people use CBD products for dealing with stress, anxiety, and sleeplessness.
But little do they know the precise ways in which CBD interacts with the endocannabinoid system of the body to give relief. ULU has decided to change this scenario by associating with 19 Harley Street Hospital.
Through this partnership, the UK-based CBD business will target people’s problems precisely with the help of medical science. It will help to yield excellent results in benefitting them in improving their health. Mr. Mo Akmal, a world-famous spine specialist, will carry out research on CBD treatments.
The Harley Street Hospital is a private hospital that is located in the heart of London. It has got many consults with excellent experience in different medical treatments. That is why ULU has chosen to partner with this hospital to explore the ways CBD can be used for treating many health problems.